• Home
  • About
  • Sales Center
  • Product
  • Gallery
  • Contact
  • Webmail

Lumexit

Generic Name: Flupentixol+Melitracen

Therapeutic Class: ANALGESIC,ANTIPYRETIC & NSAIDS


Dosage Form: Tablet


View Prescribing


  • Presentation
  • Description
  • Indications
  • Dosage & Administration
  • Side Effect
  • Precautions
  • Contraindications
  • Drug Interaction
  • Storage

Presentation

Lumexit

Lumexit Tablet  Each box contains 5x10's tablets in blister strips.

Description

Lumexit consists of two well-known and well proven compounds Flupentixol and Melitracen. Flupentixol-a neuroleptic with anxiolytic and antidepressant properties of its own when given in small doses, and Melitracen –a bipolar thymoleptic  with activating properties in low doses. In combination, the compounds render a preparation with antidepressant, anxiolytic and activating properties.

Lumexit

Indication

Lumexit is indicated in Anxiety, depression, apathy. These include-

                Psychogenic depression,

                Depressive neuroses,

                Masked depression,

Psychosomatic affections accompanied by anxiety and apathy, Menopausal depressions,         dysphoria and depression in alcoholics and drug-addicts.

Lumexit

Dosage & Administration

Adults: Usually 2 tablets daily (morning and noon). In severe cases the morning dose may be increased to 2 tablets.

Elderly: 1 tablet in the morning

Lumexit

Side Effect

In the recommended doses side effects are rare. These could be transient restlessness and insomnia.

Contraindications: Lumexit is contraindicated in the immediate recovery phase after myocardial infarction, defects in bundle-branch conduction, untreated narrow angle glaucoma, acute alcohol, barbiturate and opiate intoxications. Flupentixol-Melitracen should not be given to patients who have received a MAO-inhibitor within two weeks. Not recommended for excitable or overactive patients since its activating effect may lead to exaggeration of these characteristics.

 

Lumexit

Precautions

If previously the patient has been treated with tranquilizers with sedative effect these should be withdrawn gradually.

Lumexit

Contraindications

Lumexit is contraindicated in the immediate recovery phase after myocardial infarction, defects in bundle-branch conduction, untreated narrow angle glaucoma, acute alcohol, barbiturate and opiate intoxications. Flupentixol-Melitracen should not be given to patients who have received a MAO-inhibitor within two weeks. Not recommended for excitable or overactive patients since its activating effect may lead to exaggeration of these characteristics.

Lumexit

Drug Interaction

Lumexit may enhance the response to alcohol, barbiturates, and other CNS depressants. Simultaneous administration of MAO-inhibitors may cause hypertensive crisis. Neuroleptics and thymoleptics reduce the antihypertensive effect of guanethidine and similar acting compounds and thymoleptic enhance the effects of adrenaline and noradrenaline.

Lumexit

Storage

Lumexit should be stored at room temperature betwen 15-30  C away from light and moisture at cool and dry place.

Keep all medicines away from children.

Lumexit